What is Solar Biotech?
Solar Biotech is at the forefront of transforming the synthetic biology (SynBio) industry by delivering comprehensive, sustainable, and scalable biomanufacturing capabilities. Leveraging proprietary SynBio Hyperintegration Algorithms, the company engineers customized modular plant architectures for a diverse array of SynBio products, including biodesigned cosmetics and advanced functional food ingredients. Their BioNodes are engineered for environmental responsibility, operating on solar power and utilizing recycled water, thereby ensuring that all manufactured products are carbon-neutral and water-neutral. This approach positions Solar Biotech to effectively meet the escalating global demand for SynBio products while upholding stringent environmental stewardship.
How much funding has Solar Biotech raised?
Solar Biotech has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2021): $2M, investors not publicly disclosed
What's next for Solar Biotech?
With the recent enterprise-level investment, Solar Biotech is poised for accelerated growth and market expansion. The company's focus on sustainable and scalable biomanufacturing solutions, particularly in biodesigned cosmetics and functional food ingredients, aligns with increasing consumer and regulatory demand for eco-friendly products. Future strategic initiatives are likely to involve further development of their BioNode technology, enhancing their SynBio Hyperintegration Algorithms, and potentially forging new partnerships to broaden their product portfolio and market reach. This capital infusion will be critical in solidifying their position as a leader in sustainable SynBio.
See full Solar Biotech company page
